When a 75-year-old starts dozing on the couch for two hours every afternoon, family members tend to shrug it off as a normal part of aging. But a growing body of research suggests those long, frequent naps may be the body’s way of signaling something deeper: a heart that is quietly struggling.
A prospective cohort study published in the Journal of the American Heart Association tracked roughly 1,140 community-dwelling older adults over several years, using wrist-worn activity monitors to record exactly when and how long participants slept during the day. The results, published in 2021, were striking: longer and more frequent daytime naps predicted a higher risk of developing heart failure, even after the researchers adjusted for nighttime sleep quality, existing health conditions, and other variables that might muddy the picture.
The finding has drawn attention from geriatricians and sleep researchers because it reframes a common habit as a potential clinical red flag, one that doctors could screen for during routine checkups.
What the strongest evidence shows
What sets this heart failure study apart from earlier napping research is how sleep was measured. Instead of asking participants to recall their nap habits, which people routinely misjudge, the investigators used actigraphy: a wrist-worn device that tracks movement around the clock and distinguishes actual sleep from quiet wakefulness. That objective measurement captured patterns self-reported diaries would likely miss.
The researchers, led by Jessica Lunsford-Avery and colleagues analyzing data from the Cardiovascular Health Study, found that the association between daytime napping and incident heart failure persisted after controlling for nighttime sleep duration, body mass index, diabetes, hypertension, and other established cardiac risk factors. Their conclusion was direct: excessive daytime napping may track cardiometabolic vulnerability in aging populations.
A separate actigraphy-based investigation reinforced that pattern. Published in 2022, the study grouped older men and women into composite sleep profiles rather than isolating a single variable. Profiles dominated by high daytime inactivity and fragmented nighttime rest were associated with the highest mortality risk. Together, these two device-measured studies point in the same direction: what older adults do during the day, sleep-wise, carries real prognostic weight.
The signal extends beyond the heart. A systematic review indexed in PubMed and published in late 2022 examined napping and cognitive health across multiple observational cohorts. The authors reported an inverted-U pattern in several, though not all, of the included analyses: short or moderate naps appeared to benefit brain function, while prolonged naps, generally exceeding 60 minutes, were linked to worse cognitive outcomes. Both duration and regularity of daytime sleep seemed to shape risk, but the pattern was not universal across every study in the review.
Large population-level data from the Japan Collaborative Cohort Study, a prospective investigation led by Akiko Tamakoshi and colleagues and published in 2004, which relied on self-reported napping habits across tens of thousands of Japanese participants, also showed an association between habitual long napping and elevated all-cause and cardiovascular mortality. While self-reported data is less precise than actigraphy, the consistency across measurement methods strengthens the overall case.
Why causation remains an open question
Every study in this evidence base is observational. Researchers measured napping behavior and then watched for outcomes. They did not intervene. That distinction matters enormously, because it means the data can identify associations but cannot prove that napping itself damages the heart or the brain.
The alternative explanation is intuitive: people who nap excessively may already be experiencing subclinical heart failure, early neurodegeneration, chronic inflammation, or another condition that makes them drowsy during the day. In that scenario, the long nap is a symptom, not a cause.
No intervention trial has tested whether reducing long naps in older adults lowers the incidence of heart failure or cognitive decline. Without that kind of experiment, clinicians cannot recommend nap restriction as a preventive strategy with any confidence. The mechanistic pathways linking prolonged daytime sleep to cardiovascular damage also remain poorly defined. Some researchers have hypothesized that fragmented nighttime sleep forces compensatory daytime napping, which keeps the sympathetic nervous system activated for longer periods and stresses the heart. But primary data supporting that chain of events in humans is limited.
Other biological explanations are plausible but unproven. Prolonged daytime sleep might disrupt circadian rhythms that regulate blood pressure, glucose metabolism, and inflammatory signaling. Or chronic low-grade illness could simultaneously increase fatigue and alter sleep architecture, producing a pattern of long naps that simply mirrors declining health rather than accelerating it.
The populations studied so far also limit generalizability. The actigraphy-based heart failure cohort enrolled roughly 1,140 community-dwelling older adults in the United States, and the Japan Collaborative Cohort Study drew from a Japanese population. Diverse global cohorts spanning a wider range of ethnic backgrounds, socioeconomic conditions, and baseline health statuses have not been well represented. Most participants were relatively healthy at enrollment, leaving open questions about how napping patterns behave in people with advanced chronic disease, severe insomnia, or limited mobility.
What this means for older adults and their doctors
For older adults and their families, the practical message is specific but measured. A pattern of increasingly long or frequent daytime naps, especially naps stretching beyond 60 minutes and paired with poor nighttime sleep, is worth raising with a physician. It does not mean a 20-minute afternoon rest is dangerous. The evidence consistently distinguishes between moderate napping, which may be benign or even beneficial for alertness and mood, and prolonged or irregular napping, which tracks with worse cardiovascular and neurological outcomes.
Doctors who ask about daytime sleep habits during routine visits may catch early signs of heart failure or cognitive decline before more obvious symptoms surface. Excess daytime sleepiness can also signal untreated sleep apnea, poorly controlled pain, medication side effects, or depression. Addressing those underlying issues, rather than simply advising patients to stop napping, aligns better with what the research actually supports.
In some cases, structured brief naps earlier in the day may help older adults maintain alertness without the potential downsides associated with long, late-afternoon sleep. Geriatric sleep specialists have noted that timing and duration matter more than whether someone naps at all.
Wearable devices could change how doctors screen for risk
The research also carries a broader implication for clinical practice. Actigraphy captured associations that self-reported data alone might miss or distort. As wrist-worn devices and consumer-grade sleep trackers become cheaper and more widespread, objective sleep monitoring could become a standard part of geriatric assessment.
That shift would give physicians a clearer window into a patient’s daily rhythms and the subtle changes that precede overt disease. As of May 2026, no major medical society has issued formal guidelines recommending actigraphy-based nap screening in older adults, but the accumulating evidence is pushing the conversation in that direction. Used thoughtfully, these tools might help distinguish between restorative rest and a quiet warning that the heart, or the brain, is losing ground.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
